Chronic News and Research

RSS

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors - the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.

11 Oct 2013

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Researchers at the University of California, San Diego School of Medicine have identified 13 metabolites - small molecules produced by cellular metabolism - that are significantly different in patients with diabetes and chronic kidney disease compared to healthy controls.

11 Oct 2013

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.

11 Oct 2013

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

The U.S. Food and Drug Administration today approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis either before transplant, or after renal (kidney) transplantation in which there is recurrence of FSGS.

11 Oct 2013

FDA clears Sotera Wireless' patented continuous non-invasive blood pressure technology

Sotera Wireless, Inc. today announced the U.S. Food and Drug Administration has cleared the Company's patented continuous non-invasive blood pressure technology, a new feature of the ViSi Mobile wireless patient monitoring system. For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the use of a catheter or blood pressure cuff.

10 Oct 2013

New research shows high levels of aluminium in infant formulas

New research from Keele University shows that infant formulas are still heavily contaminated with aluminium.

10 Oct 2013

Phase 3 study of idelalisibin reports positive results in CLL patients

Following a recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase 3 study (Study 116) evaluating idelalisib in previously-treated chronic lymphocytic leukemia (CLL) patients who are not fit for chemotherapy will be stopped early.

10 Oct 2013

Pfizer reports positive results from two tofacitinib Phase 3 trials for chronic plaque psoriasis

Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).

10 Oct 2013

$New report provides fracture prevention, management solutions for postmenopausal woman$

New report provides fracture prevention, management solutions for postmenopausal woman

According to a new report published today by the International Osteoporosis Foundation, women may expect to live longer but their quality of life will be seriously jeopardized if action to protect their bone health is not taken. Postmenopausal women are the most vulnerable to osteoporosis and fractures. Worldwide, an estimated 200 million women are affected by osteoporosis and around one in three women aged over 50 will suffer from a fracture due to the disease.

10 Oct 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.

10 Oct 2013

Hypertension affects over 40% of Chinese adults, shows WHO report

With a recent World Health Organization report showing hypertension affects over 40% of Chinese adults aged 45 or older, combating high blood pressure will be high on the agenda of the 24th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress, in Beijing (10 to 13 October 2013).

10 Oct 2013

Scientists create model in battle against adenomyosis

For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.

10 Oct 2013

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

As we age, most of us come to depend on prescription drugs to help us live healthier, longer lives. But the very medications that we count on for better health could also land us in the hospital.

10 Oct 2013

Study associates high polyphenols intake with 30% reduction in mortality in older adults

It is the first time that a scientific study associates high polyphenols intake with a 30% reduction in mortality in older adults. The research, published on Journal of Nutrition, is the first to evaluate the total dietary polyphenol intake by using a nutritional biomarker and not only a food frequency questionnaire.

10 Oct 2013

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.

10 Oct 2013

Chronic News and Research

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

FDA clears Sotera Wireless' patented continuous non-invasive blood pressure technology

New research shows high levels of aluminium in infant formulas

Phase 3 study of idelalisibin reports positive results in CLL patients

Pfizer reports positive results from two tofacitinib Phase 3 trials for chronic plaque psoriasis

New report provides fracture prevention, management solutions for postmenopausal woman

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Hypertension affects over 40% of Chinese adults, shows WHO report

Scientists create model in battle against adenomyosis

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

Study associates high polyphenols intake with 30% reduction in mortality in older adults

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Dry eye disease symptom change independent of tear osmolarity

Asthma infection risk ‘goes beyond the airways’

U.S. Army Grants QR Pharma, UCLA $3M To Test TBI Treatment

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

Community Health Centers shifting toward more holistic, population-based care

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News